Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × tilsotolimod × Clear all

Phase

Phase 3 1 Phase 1 1

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Cyclophosphamide 91 pembrolizumab 72 Gemcitabine 67 fludarabine 57 Nivolumab 50 Carboplatin 49 Radiotherapy 45 Rituximab 44 Cisplatin 44 Paclitaxel 43 Docetaxel 42 Lenalidomide 37 Dexamethasone 36 Ipilimumab 34 Cytarabine 31 Radiation 29 Etoposide 29 Azacitidine 28 Temozolomide 27 venetoclax 25 Bevacizumab 25 Bortezomib 23 Capecitabine 22 Pemetrexed 21 fludarabine phosphate 20 Magnetic Resonance Spectroscopy 20 atezolizumab 19 Oxaliplatin 19 Interleukin-2 19 Everolimus 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04270864 2024-10-18

PRIMO

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Terminated

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡